Why the study?
Does trandolapril and/or verapamil improve endothelial function and reduce blood pressure in spontaneously hypertensive, stroke-prone rats?
Does trandolapril and/or verapamil improve endothelial function and reduce blood pressure in spontaneously hypertensive, stroke-prone rats?
Both low-dose combination and monotherapy with an ACE inhibitor and calcium antagonist have comparable beneficial effects on blood pressure and endothelial function in a hypertensive rat model.
Rat findings warrant no clinical practice change; leaves open translation of ACEI/CCB endothelial effects to humans.
Summary: The effects of chronic therapy with the angiotensin-converting enzyme (ACE) inhibitor trandolapril and/or Ca2+ antagonist verapamil on endothelial and vascular smooth muscle (VSM) function were studied in spontaneously hypertensive, stroke-prone rats (SHR-SP). Dosages decreasing systolic blood pressure (SBP) by 20% were administered orally (p.o.) by gavage as monotherapy or combination therapy for 8 weeks, beginning at age 6 weeks. Combination therapy dosages were the same as those used in monotherapy (trandolapril 0.7 mg/kg/day verapamil 20 mg/kg/day) in one group; the second group received only half the monotherapy dosage. The study was placebo-controlled and performed in parallel groups. Isometric tension was measured in aortic rings suspended in organ chambers (95% C2/5% CO2; 37°C). SBP decreased in all groups, as compared with placebo [30-47 mm Hg, analysis of variance (ANOVA), p < 0.05], but decrease was more pronounced in rats receiving high-dose combination (76 mm Hg, ANOVA, p < 0.05). In norepinephrine (NE)-contracted rings, endothelium-dependent relaxation to acetylcholine (ACh) was augmented similarly with all forms of therapy (maximal relaxations 89-94%) as compared with placebo (64 ± 6%, p < 0.05). In contrast, the response to sodium nitroprusside (SNP) was similar in all groups (NS). In quiescent rings, ACh elicited endothelium-dependent contractions (in the presence of Nω-monomethyl-L-arginine, L-NAME) that were not affected by therapy. In rings of untreated SHR-SP incubated with a thromboxane receptor antagonist (SQ 30741), the reduced endothelium-dependent relaxation to ACh was corrected, indicating that the main effect must be an increase in release of nitric oxide (NO) relative to that of thromboxane (TXA2)/prostaglandin H2 (PGH2). Both antihypertensive therapy with a combination of ACE inhibitor and Ca2+ antagonist at low dosage and monotherapy have comparable effects on BP pressure and endothelial function.
No takes yet. Share an insight, caveat, or question.
Novosel et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: